151 related articles for article (PubMed ID: 11044213)
1. Differential expression of renal AGE-receptor genes in NOD mice: possible role in nonobese diabetic renal disease.
He CJ; Zheng F; Stitt A; Striker L; Hattori M; Vlassara H
Kidney Int; 2000 Nov; 58(5):1931-40. PubMed ID: 11044213
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells.
Lu C; He JC; Cai W; Liu H; Zhu L; Vlassara H
Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11767-72. PubMed ID: 15289604
[TBL] [Abstract][Full Text] [Related]
3. Presence of diabetic complications in type 1 diabetic patients correlates with low expression of mononuclear cell AGE-receptor-1 and elevated serum AGE.
He CJ; Koschinsky T; Buenting C; Vlassara H
Mol Med; 2001 Mar; 7(3):159-68. PubMed ID: 11471552
[TBL] [Abstract][Full Text] [Related]
4. Gene expression of receptor for advanced glycosylation end products and its modulation by aminoguanidine in diabetic kidney tissue.
Huang Y; Lin S; Zhou J
Chin Med J (Engl); 1998 Aug; 111(8):698-704. PubMed ID: 11245022
[TBL] [Abstract][Full Text] [Related]
5. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.
Okada M; Takemura T; Yanagida H; Yoshioka K
Kidney Int; 2002 Jan; 61(1):113-24. PubMed ID: 11786091
[TBL] [Abstract][Full Text] [Related]
6. [Effect of xianzhen tablet on content of advanced glycosylation end products (AGEs) and mRNA expression of AGE-specific cellular receptor in renal cortex of diabetic rats].
Tang DY; Guo SS; Sun RY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Jan; 25(1):60-3. PubMed ID: 15719755
[TBL] [Abstract][Full Text] [Related]
7. Relationship between the expression of advanced glycation end-products (AGE) and the receptor for AGE (RAGE) mRNA in diabetic nephropathy.
Suzuki D; Toyoda M; Yamamoto N; Miyauchi M; Katoh M; Kimura M; Maruyama M; Honma M; Umezono T; Yagame M
Intern Med; 2006; 45(7):435-41. PubMed ID: 16679697
[TBL] [Abstract][Full Text] [Related]
8. [Extract of Ginkgo biloba and alpha-lipoic acid attenuate advanced glycation end products accumulation and RAGE expression in diabetic nephropathy rats].
Li XZ; Yan HD; Wang J
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Apr; 31(4):525-31. PubMed ID: 21608227
[TBL] [Abstract][Full Text] [Related]
9. [Effects of irbesartan on renal advanced glycation end products and their receptor in rats with early diabetic nephropathy].
Long HB; Niu HX; Li XY; Zhou WD; He JH; Zhong J; Wei LB
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Dec; 29(12):2433-6, 2441. PubMed ID: 20034895
[TBL] [Abstract][Full Text] [Related]
10. Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-induced monocyte chemoattractant protein-1 expression in mesangial cells through downregulation of receptor for AGEs via peroxisome proliferator-activated receptor-gamma activation.
Matsui T; Yamagishi S; Ueda S; Nakamura K; Imaizumi T; Takeuchi M; Inoue H
J Int Med Res; 2007; 35(4):482-9. PubMed ID: 17697525
[TBL] [Abstract][Full Text] [Related]
11. Galectin-3/AGE-receptor 3 knockout mice show accelerated AGE-induced glomerular injury: evidence for a protective role of galectin-3 as an AGE receptor.
Iacobini C; Menini S; Oddi G; Ricci C; Amadio L; Pricci F; Olivieri A; Sorcini M; Di Mario U; Pesce C; Pugliese G
FASEB J; 2004 Nov; 18(14):1773-5. PubMed ID: 15361471
[TBL] [Abstract][Full Text] [Related]
12. Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products.
Zheng F; He C; Cai W; Hattori M; Steffes M; Vlassara H
Diabetes Metab Res Rev; 2002; 18(3):224-37. PubMed ID: 12112941
[TBL] [Abstract][Full Text] [Related]
13. IGF-1 decreases collagen degradation in diabetic NOD mesangial cells: implications for diabetic nephropathy.
Lupia E; Elliot SJ; Lenz O; Zheng F; Hattori M; Striker GE; Striker LJ
Diabetes; 1999 Aug; 48(8):1638-44. PubMed ID: 10426384
[TBL] [Abstract][Full Text] [Related]
14. Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products.
Lassila M; Seah KK; Allen TJ; Thallas V; Thomas MC; Candido R; Burns WC; Forbes JM; Calkin AC; Cooper ME; Jandeleit-Dahm KA
J Am Soc Nephrol; 2004 Aug; 15(8):2125-38. PubMed ID: 15284298
[TBL] [Abstract][Full Text] [Related]
15. Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy.
Tan AL; Sourris KC; Harcourt BE; Thallas-Bonke V; Penfold S; Andrikopoulos S; Thomas MC; O'Brien RC; Bierhaus A; Cooper ME; Forbes JM; Coughlan MT
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F763-70. PubMed ID: 20015941
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of glyoxalase 1 by mangiferin prevents diabetic nephropathy progression in streptozotocin-induced diabetic rats.
Liu YW; Zhu X; Zhang L; Lu Q; Wang JY; Zhang F; Guo H; Yin JL; Yin XX
Eur J Pharmacol; 2013 Dec; 721(1-3):355-64. PubMed ID: 24036348
[TBL] [Abstract][Full Text] [Related]
17. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice.
Yamamoto Y; Kato I; Doi T; Yonekura H; Ohashi S; Takeuchi M; Watanabe T; Yamagishi S; Sakurai S; Takasawa S; Okamoto H; Yamamoto H
J Clin Invest; 2001 Jul; 108(2):261-8. PubMed ID: 11457879
[TBL] [Abstract][Full Text] [Related]
18. Temporal increases in urinary carboxymethyllysine correlate with albuminuria development in diabetes.
Coughlan MT; Forbes JM
Am J Nephrol; 2011; 34(1):9-17. PubMed ID: 21654162
[TBL] [Abstract][Full Text] [Related]
19. Lysozyme enhances renal excretion of advanced glycation endproducts in vivo and suppresses adverse age-mediated cellular effects in vitro: a potential AGE sequestration therapy for diabetic nephropathy?
Zheng F; Cai W; Mitsuhashi T; Vlassara H
Mol Med; 2001 Nov; 7(11):737-47. PubMed ID: 11788787
[TBL] [Abstract][Full Text] [Related]
20. RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin.
Myint KM; Yamamoto Y; Doi T; Kato I; Harashima A; Yonekura H; Watanabe T; Shinohara H; Takeuchi M; Tsuneyama K; Hashimoto N; Asano M; Takasawa S; Okamoto H; Yamamoto H
Diabetes; 2006 Sep; 55(9):2510-22. PubMed ID: 16936199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
